Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming

The use of recombinant tumor antigen proteins is a realistic approach for the development of generic cancer vaccines, but the potential of this type of vaccines to induce specific CD8(+) T cell responses, through in vivo cross-priming, has remained unclear. In this article, we report that repeated v...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Valmori, Danila, Souleimanian, Naira E., Tosello, Valeria, Bhardwaj, Nina, Adams, Sylvia, O'Neill, David, Pavlick, Anna, Escalon, Juliet B., Cruz, Crystal M., Angiulli, Angelica, Angiulli, Francesca, Mears, Gregory, Vogel, Susan M., Pan, Linda, Jungbluth, Achim A., Hoffmann, Eric W., Venhaus, Ralph, Ritter, Gerd, Old, Lloyd J., Ayyoub, Maha
Format: Artigo
Sprache:Inglês
Veröffentlicht: National Academy of Sciences 2007
Schlagworte:
Biological Sciences
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1885608/
https://ncbi.nlm.nih.gov/pubmed/17517626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0703395104
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge